Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra: Possible implications for Parkinson's disease

Neuroscience

Volumn 83, Issue 3, 1998, Pages 791-798

  Ross, B M ^a   Moszczynska, A ^a   Erlich, J ^a   Kish, S J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Oxidative stress; Parkinson's disease; Phosphocholine cytidylyltransferase; Phosphoethanolamine cytidylyltransferase; Phospholipase A2; Substantia nigra

Indexed keywords

CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE; ETHANOLAMINE PHOSPHOTRANSFERASE; PHOSPHOLIPASE A2;

ARTICLE; DEGENERATIVE DISEASE; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN TISSUE; OXIDATIVE STRESS; PARKINSON DISEASE; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ACYLTRANSFERASES; AGED; CADAVER; ENZYMES; HUMANS; LYSOPHOSPHOLIPASE; MIDDLE AGED; PARKINSON DISEASE; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PHOSPHORIC DIESTER HYDROLASES; REFERENCE VALUES; SUBSTANTIA NIGRA;

EID: 0032484497     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00454-5     Document Type: Article

References (29)

1. 2. Biosci. Biotech. Biochem. 57, 2200-2201.
2. 1 macrophages. Proc. natn. Acad. Sci. U.S.A. 92, 8527-8531.
3. 3. Beckman J. K., Borowitz S. M. and Burr I. M. (1987) The role of phospholipase A activity in rat liver microsomal preparations. J. biol. Chem. 262, 1479-1484.
4. 4. Cornell R. B. (1992) Cholinephosphotransferase from a mammalian source. Meth. Enzymol. 209, 267-272.
5. 5. Denisova N. A., Gorbunov N. V. and Avrova N. F. (1991) Fatty acid composition of phospholipids of myelin and synaptosomal proteolipid complexes from vertebrate brain. Int. J. Biochem. 23, 811-818.
6. 6. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P. and Marsden C. D. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52, 381-389.
7. 7. Dexter D. T., Holley A. E., Flitter W. D., Slater T. F., Wells F. R., Daniel S. E., Lees A. J., Jenner P. and Marsden C. D. (1994) Increased levels of lipid hydroperoxides in the Parkinsonian substantia nigra: an HPLC and ESR study. Movement Disord. 9, 92-97.
8. 8. Halliwell B. and Gutteridge J. M. (1985) Lipid peroxidation: a radical chain reaction. In Free Radicals in Biology and Medicine, pp. 139-189. Clarendon, Oxford.
9. 9. Hochmann Y., Zakim D. and Vessey D. A. (1981) A kinetic mechanism for modulation of the activity of microsomal UDP-glucuronyltransferase by phospholipids. Effects of lysophosphatidylcholines. J. biol. Chem. 256, 4783-4788.
10. 10. Kent C. (1990) Regulation of phosphatidylcholine biosynthesis. Prog. Lipid Res. 29, 87-105.
11. 11. Martinez-Cayuela M. (1995) Oxygen free radicals and human disease. Biochimie 77, 147-161.
12. 2 by peroxidized phospholipids. Lipids 28, 505-509.
13. 13. Perry T. L. (1982) Cerebral amino acid pools. In Handbook of Neurochemistry (ed. Lajtha A.), Vol. 1, 2nd edn, pp. 151-180. Plenum, New York.
14. 14. Ramos-Sanchez J. R. and Overik E. (1994) A marker of oxyradical-mediated DNA damage (8-hydroxy-2′-deoxyguanosine) is increased in nigro-striatum of Parkinson's diseased brain. Neurodegeneration 3, 197-204.
15. 15. Ross B. M. and Kish S. J. (1994) Characterisation of lysophospholipid metabolising enzymes in human brain. J. Neurochem. 63, 1839-1848.
16. 2 activity in human brain. J. Neurochem. 64, 2213-2221.
17. 2 activity is selectively decreased in the striatum of chronic cocaine users. J. Neurochem. 67, 2620-2623.
18. 18. Ross B. M., Moszczynska A., Blusztajn J. K., Sherwin A., Lozano A. and Kish S. J. (1997) Phospholipid biosynthetic enzymes in human brain. Lipids 32, 251-258.
19. 19. Ross B. M., Sherwin A. L. and Kish S. J. (1995) Multiple forms of the enzyme glycerophosphodiesterase are present in human brain. Lipids 30, 1075-1081.
20. 20. Saggu H., Cooksey J., Dexter D., Wells F. R., Lees A., Jenner P. and Marsden C. D. (1989) A selective increase in particulate superoxide dismutase activity in Parkinson's substantia nigra. J. Neurochem. 52, 515-520.
21. 2 in 1-palmitoyl-2-oleoyl-sn-3-phosphocholine liposomes containing lipid ozonation products. Chem. Res. Toxicol. 7, 458-462.
22. 22. Schapira A. H. V. (1996) Oxidative stress in Parkinson's disease. Neuropath. appl. Neurobiol. 21, 3-9.
23. 23. Sian J., Dexter D. T., Lees A. J., Daniel S., Jenner P. and Marsden C. D. (1994) Glutathione-related enzymes in brain in Parkinson's disease. Ann. Neurol. 36, 356-361.
24. 24. Soderberg M., Edlund C., Kristensson K. and Dallner G. (1990) Lipid compositions of different regions of the human brain during aging. J. Neurochem. 54, 415-423.
25. 2. Biochem. J. 220, 243-252.
26. 26. Ursini F., Maiorino M., Valente M., Ferri L. and Gregolin C. (1982) Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim. biophys. Acta 710, 197-211.
27. 2: a monolayer study. Biochemistry 32, 4962-4967.
28. 2: protection of membranes from lipid peroxidation damage. Trends biochem. Sci. 12, 31-34.
29. 29. Weltzien H. U. (1979) Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim. biophys. Acta 559, 259-287.